coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far.Dr Robin Shattock, a professor at the college, told The Associated Press that he and colleagues had just finished a very slow and arduous process of testing the vaccine at a low dose in the initial participants and would now expand the trial to about 300 people, including some over age 75."It's well tolerated.